These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Performance of immunochemical fecal occult blood tests among users of low-dose aspirin. Chan YH; Schooling CM JAMA; 2011 Mar; 305(11):1093; author reply 1093-4. PubMed ID: 21406642 [No Abstract] [Full Text] [Related]
23. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Worthley DL; Smith A; Bampton PA; Cole SR; Young GP Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514 [TBL] [Abstract][Full Text] [Related]
24. [Controversies of postoperative nonsteroidal anti-inflammatory drug use]. Autret-Leca E; Bensouda-Grimaldi L; Goldwirt L; Jonville-Béra AP Arch Pediatr; 2007 Aug; 14(8):955-7. PubMed ID: 17572077 [No Abstract] [Full Text] [Related]
25. Fecal occult blood testing for iron deficiency: a reappraisal. Harewood GC; Ahlquist DA Dig Dis; 2000; 18(2):75-82. PubMed ID: 11060470 [TBL] [Abstract][Full Text] [Related]
26. Celecoxib-induced upper gastrointestinal hemorrhage and ulceration. Crawford AS; White JG South Med J; 2002 Dec; 95(12):1444-6. PubMed ID: 12597315 [TBL] [Abstract][Full Text] [Related]
27. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening. Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827 [TBL] [Abstract][Full Text] [Related]
28. Comparison of predictive value for colorectal cancer in subjects with and without rectal bleeding. Nakama H; Kayano T; Katsuura T; Kamigaito T; Shimada S; Nishikawa N; Yoshii S; Kamijo N Hepatogastroenterology; 1999; 46(27):1730-2. PubMed ID: 10430332 [TBL] [Abstract][Full Text] [Related]
29. A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding. Stray N; Weberg R Scand J Gastroenterol; 2006 Jul; 41(7):844-50. PubMed ID: 16785199 [TBL] [Abstract][Full Text] [Related]
30. [The Hemocult test in screening of colo-rectal cancer: sensitivity, specificity, and positive predictive value]. Feydy P Gastroenterol Clin Biol; 1990; 14(3):296-7. PubMed ID: 2344920 [No Abstract] [Full Text] [Related]
33. Fecal occult blood testing: clinical value and limitations. Simon JB Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118 [TBL] [Abstract][Full Text] [Related]
34. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin]. Thiéfin G Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912 [No Abstract] [Full Text] [Related]
35. [[Evaluation of various methods of studying fecal occult blood]. Vandenbroucke A; Bourdon C; Ilunga J Acta Gastroenterol Belg; 1988; 51(4-5):383-90. PubMed ID: 2979053 [TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal blood loss in arthritic patients receiving chronic dosing with etodolac and piroxicam. Jallad NS; Sanda M; Salom IL; Perdomo CS; Garg DC; Mullane JF; Weidler DJ Am J Med Sci; 1986 Nov; 292(5):272-6. PubMed ID: 2946224 [TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer detection in the practice setting. Impact of fecal blood testing. Ahlquist DA; Klee GG; McGill DB; Ellesfon RD Arch Intern Med; 1990 May; 150(5):1041-5. PubMed ID: 2331185 [TBL] [Abstract][Full Text] [Related]
38. Colonic side effects of nonsteroidal antiinflammatory drugs. Kaminaga N; Parra-Blanco A; Fujita R Intern Med; 1999 Mar; 38(3):219-20. PubMed ID: 10337927 [No Abstract] [Full Text] [Related]
40. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh. Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]